Contineum Therapeutics Rings the Closing Bell
About This Event
Contineum Therapeutics (Nasdaq: CTNM), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology (NI&I) indications, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Carmine Stengone, President & CEO, rings the Closing Bell.